Table 2.
Albendazole medication in patients with echinococcosis in the 10 endemic counties in 2019
| General characteristics | Total (n) | Medication | H | P-value | ||
|---|---|---|---|---|---|---|
| No medication (n, %) | Irregular medication (n, %) | Regular medication (n, %) | ||||
| Sex | ||||||
| Male | 214 | 10 (4.7) | 155 (72.4) | 49 (22.9) | 4.12 | 0.12 |
| Female | 368 | 36 (9.8) | 248 (67.4) | 84 (22.8) | ||
| Age (year) | ||||||
| < 18 | 13 | 3 (23.1) | 8 (61.5) | 2 (15.4) | 3.89 | 0.14 |
| 18–40 | 52 | 1 (1.9) | 36 (69.2) | 15 (28.9) | ||
| 40–60 | 178 | 15 (8.4) | 127 (71.4) | 36 (20.3) | ||
| ≥ 60 | 339 | 27 (8.0) | 232 (68.4) | 80 (23.6) | ||
| Ethnicity | ||||||
| Han | 268 | 1 (0.4) | 193 (72.0) | 74 (27.6) | 34.76* | < 0.05 |
| Tibetan | 293 | 44 (15.0) | 191 (65.2) | 58 (19.8) | ||
| Others | 21 | 1 (4.2) | 19 (90.5) | 1 (4.2) | ||
| Education level | ||||||
| No formal education | 353 | 38 (10.8) | 224 (63.5) | 91 (25.8) | 46.12** | < 0.05 |
| Primary school | 164 | 6 (3.7) | 133 (81.1) | 25 (15.2) | ||
| Junior high school | 62 | 2 (3.2) | 45 (28.6) | 15 (24.2) | ||
| Senior high school and above | 3 | 0 | 1 (33.3) | 2 (66.7) | ||
| Occupation | ||||||
| Herdsmen | 245 | 37 (15.1) | 156 (63.7) | 52 (21.2) | 31.69 | < 0.05 |
| Farmers | 286 | 5 (1.8) | 206 (72.0) | 75 (26.2) | ||
| Others | 51 | 4 (7.8) | 41 (80.4) | 6 (11.7) | ||
| Disease type | ||||||
| CE | 563 | 46 (8.2) | 403 (71.6) | 114 (20.3) | 10.76 | < 0.05 |
| AE | 19 | 0 | 0 | 19 (100.0) | ||
| Disease duration (year) | ||||||
| < 5 | 91 | 22 (24.2) | 25 (27.5) | 44 (48.4) | 6.13 | < 0.05 |
| 5–10 | 422 | 23 (5.5) | 329 (78.0) | 70 (16.6) | ||
| ≥ 10 | 69 | 1 (1.5) | 49 (71.0) | 19 (27.5) | ||
| Albendazole dosage form | ||||||
| Tablet | 200 | 0 | 150 (75.0) | 50 (25.0) | 8.70 | < 0.05 |
| Emulsion | 178 | 3 (1.7) | 146 (82.0) | 29 (16.3) | ||
| Tablet + emulsion | 111 | 0 | 63 (56.8) | 48 (43.2) | ||
| Unrecorded | 93 | 43 (46.2) | 44 (47.3) | 6 (6.5) | ||
| Occurrence of adverse reactions (Excluding patients without medication, N = 536) | ||||||
| Yes | 242 | – | 207 (85.5) | 35 (14.5) | 6.24 | < 0.05 |
| No | 294 | – | 194 (66.0) | 100 (34.0) | ||
| Total | 582 | 46 (7.9) | 403 (69.2) | 133 (22.9) | ||
The chi-square test compared only with the recorded percentage
CE cystic echinococcosis; AE alveolar echinococcosis
*Fewer patients from other ethnic groups and only Tibetan and Han patients were included in the analysis
**Fewer patients in senior high school, college, and beyond, and these patients were merged in the analysis
†P values were compared with the 0.05 level